Gilead Sciences (GILD) Short-term Investments (2009 - 2026)

Gilead Sciences (GILD) has reported Short-term Investments for 17 consecutive years, with $15.0 million the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Short-term Investments changed N/A year-over-year to $15.0 million; the trailing twelve-month figure through Mar 2026 stood at $15.0 million (changed N/A YoY), and the FY2025 full-year result was $68.0 million, changed N/A from the prior year.
• Short-term Investments eased to $15.0 million in Q1 2026 per GILD's latest filing, from $68.0 million in the prior quarter.
• Across five years, Short-term Investments topped out at $1.2 billion in Q4 2023 and bottomed at $15.0 million in Q1 2026.
• Historically, Short-term Investments has averaged $691.2 million across 4 years, with a median of $948.5 million in 2022.
• The sharpest annual moves came in 2022 and 2023: Short-term Investments sank 43.38% in 2022, then advanced 21.17% in 2023.
• Over 4 years, Short-term Investments stood at $973.0 million in 2022, then climbed by 21.17% to $1.2 billion in 2023, then plunged by 94.23% to $68.0 million in 2025, then plunged by 77.94% to $15.0 million in 2026.
• According to Business Quant data, Short-term Investments over the past three periods registered $15.0 million, $68.0 million, and $19.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.